---
figid: PMC5924752__41419_2018_522_Fig6_HTML
figtitle: O-GlcNAc elevation through activation of the hexosamine biosynthetic pathway
  enhances cancer cell chemoresistance
organisms:
- NA
pmcid: PMC5924752
filename: 41419_2018_522_Fig6_HTML.jpg
figlink: /pmc/articles/PMC5924752/figure/Fig6/
number: F6
caption: Chemotherapeutic drugs, such as DOX and CPT, stimulate AKT/XBP1 and then
  induce GFAT through upregulation of the HBP and O-GlcNAcylation. Excess O-GlcNAc
  leads to cell survival by inhibiting the apoptotic function of caspases and activating
  pro-survival transcription factors, such as NF-κB and AKT
papertitle: O-GlcNAc elevation through activation of the hexosamine biosynthetic pathway
  enhances cancer cell chemoresistance.
reftext: Yubo Liu, et al. Cell Death Dis. 2018 May;9(5):485.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9406579
figid_alias: PMC5924752__F6
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC5924752__F6
ndex: a3555810-defe-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5924752__41419_2018_522_Fig6_HTML.html
  '@type': Dataset
  description: Chemotherapeutic drugs, such as DOX and CPT, stimulate AKT/XBP1 and
    then induce GFAT through upregulation of the HBP and O-GlcNAcylation. Excess O-GlcNAc
    leads to cell survival by inhibiting the apoptotic function of caspases and activating
    pro-survival transcription factors, such as NF-κB and AKT
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cpt
  - CG7149
  - CPT2
  - Rpn3
  - Dox-3
  - Akt
  - Dronc
  - Decay
  - Dif
  - dl
  - Rel
  - Xbp1
  - Gfat1
  - sxc
  - CHPT1
  - DHDDS
  - AKT1
  - AKT2
  - AKT3
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - XBP1
  - XBP1P1
  - GFPT1
  - GFPT2
  - AZU1
  - HDLBP
  - SLBP
  - STAM2
  - HEBP1
  - OGT
  - EOGT
  - POMGNT1
  - POMGNT2
  - DOX
  - CPT
  - UDP
  - GlcNAc
  - O
---
